VICTORIA BARNES: Open Payments
NPI 1043756745 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 44 payments from 8 companies in 2025. Trend: 2023 $329 · 2024 $1,010 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $236 |
| Regeneron Healthcare Solutions, Inc. | 11 | $202 |
| GENZYME CORPORATION | 7 | $165 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $75 |
| Amgen Inc. | 2 | $32 |
| Integra LifeSciences Corporation | 1 | $19 |
| Blueprint Medicines Corporation | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: DUPIXENT, NUCALA, NEFFY, TEZSPIRE, ACCLARENT AERA, AYVAKIT.
Industry payments across VA — which companies pay providers there.
